Overview

Study of Dexpramipexole Chronic Sinusitis With Nasal Polyps and Eosinophilia

Status:
Completed
Trial end date:
2017-01-20
Target enrollment:
Participant gender:
Summary
Phase 2, open-label, multi-center study to evaluate the clinical effects of oral administration of dexpramipexole for 6 months in subjects with chronic sinusitis with nasal polyps and eosinophilia.
Phase:
Phase 2
Details
Lead Sponsor:
Knopp Biosciences
Treatments:
Pramipexole